Dr. Laraque is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
33 Beaver St, 13th fl
NYC DHS/DSS
New York, NY 10004Phone+1 212-361-7990
Education & Training
- New York City Department of Health and Mental HygieneFellowship, Public Health and General Preventive Medicine, 1996 - 1997
- New York Downtown HospitalResidency, Internal Medicine, 1994 - 1996
- University of HaitiClass of 1985
- Columbia UniversityEpidemic Intelligence Service
Certifications & Licensure
- NY State Medical License 1996 - 2025
Clinical Trials
- Rapid Diagnostics for HIV and Hepatitis Start of enrollment: 2014 May 01
- Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 5 citationsEvaluating reimbursement of integrated support services using chronic care management (CCM) codes for treatment of hepatitis C among Medicare beneficiaries.Kyle Fluegge, Marie P. Bresnahan, Fabienne Laraque, Alain H. Litwin, Ponni V. Perumalswami
Journal of Healthcare Risk Management. 2019-10-01 - 1 citationsPublic Health Management of Persons Under Investigation for Ebola Virus Disease in New York City, 2014-2016.Ann Winters, Maryam Iqbal, Isaac Benowitz, Jennifer Baumgartner, Neil M. Vora
Public Health Reports. 2019-08-19 - 7 citationsA Cost Reimbursement Model for Hepatitis C Treatment Care Coordination.Czarina N Behrends, Ashley A. Eggman, Sarah Gutkind, Marie P. Bresnahan, Kyle Fluegge
Journal of Public Health Management and Practice. 2019-05-01
Press Mentions
- Food at Women’s Homeless Shelter Left Me ‘Suffering from Malnutrition’November 21st, 2019
- Researchers: Hepatitis C Virus Control Needs a Public Health ApproachOctober 13th, 2017
- Transmission from One Child to Another of Human Immunodeficiency Virus Type 1 with a Zidovudine-Resistance MutationDecember 16th, 1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: